Bio Pharma Dive

article thumbnail

Give HCPs a proactive way to reach your field team: Add inbound

Bio Pharma Dive

HCPs today want inbound channels for help when they need it. See how you can meet their preferences.

139
139
article thumbnail

Madrigal, FDA approval in hand, outlines plan to sell MASH drug

Bio Pharma Dive

The company expects initial uptake of Rezdiffra, which costs $47,400 per year, to be slow as doctors and insurers establish the protocols needed to find patients eligible for treatment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AstraZeneca adds another rare disease drug in $800M buyout of startup Amolyt

Bio Pharma Dive

The deal gives AstraZeneca a prospect in late-stage testing for parathyroidism and bolsters a rare disease portfolio that mainly consists of drugs from Alexion.

Drugs 164
article thumbnail

Amylyx CEOs look for a path forward following major setback

Bio Pharma Dive

Justin Klee and Joshua Cohen spoke to BioPharma Dive about the next steps for their company, which is considering pulling its only product from market after the drug failed a confirmatory study in ALS.

article thumbnail

Obesity drug from Boehringer, Zealand succeeds in MASH trial

Bio Pharma Dive

Zealand shares rose by more than one-third on the data, which provide further evidence so-called incretin drugs could help treat people with the liver disease.

Drugs 280
article thumbnail

Outgoing AbbVie CEO leaves a divisive Humira legacy and lasting impact on pharma

Bio Pharma Dive

Richard Gonzalez led AbbVie to become one of the largest pharmaceutical firms, but the company's pricing and patent tactics brought criticism and scrutiny, too.

148
148
article thumbnail

Frontier gets $80M, Galapagos’ backing to make a better KRAS drug

Bio Pharma Dive

The startup’s Series C round will support a clinical-stage drug the company thinks could address some of the weaknesses of other KRAS-targeting medicines.

Drugs 300